YU43170B - Process for obtaining crystalline benzo-sulphonate salts of sultamicillin - Google Patents

Process for obtaining crystalline benzo-sulphonate salts of sultamicillin

Info

Publication number
YU43170B
YU43170B YU904/83A YU90483A YU43170B YU 43170 B YU43170 B YU 43170B YU 904/83 A YU904/83 A YU 904/83A YU 90483 A YU90483 A YU 90483A YU 43170 B YU43170 B YU 43170B
Authority
YU
Yugoslavia
Prior art keywords
sultamicillin
benzo
obtaining crystalline
sulphonate salts
sulphonate
Prior art date
Application number
YU904/83A
Other languages
English (en)
Other versions
YU90483A (en
Inventor
W E Barth
V J Jasys
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of YU90483A publication Critical patent/YU90483A/xx
Publication of YU43170B publication Critical patent/YU43170B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
YU904/83A 1982-04-23 1983-04-21 Process for obtaining crystalline benzo-sulphonate salts of sultamicillin YU43170B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (2)

Publication Number Publication Date
YU90483A YU90483A (en) 1986-04-30
YU43170B true YU43170B (en) 1989-04-30

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
YU904/83A YU43170B (en) 1982-04-23 1983-04-21 Process for obtaining crystalline benzo-sulphonate salts of sultamicillin

Country Status (27)

Country Link
US (1) US4432987A (cg-RX-API-DMAC7.html)
EP (1) EP0092968B1 (cg-RX-API-DMAC7.html)
JP (1) JPS58201792A (cg-RX-API-DMAC7.html)
KR (1) KR860001279B1 (cg-RX-API-DMAC7.html)
AU (1) AU536854B2 (cg-RX-API-DMAC7.html)
CA (1) CA1187484A (cg-RX-API-DMAC7.html)
CS (1) CS235320B2 (cg-RX-API-DMAC7.html)
DD (1) DD209632A5 (cg-RX-API-DMAC7.html)
DE (1) DE3362502D1 (cg-RX-API-DMAC7.html)
DK (1) DK162168C (cg-RX-API-DMAC7.html)
EG (1) EG16412A (cg-RX-API-DMAC7.html)
ES (1) ES521728A0 (cg-RX-API-DMAC7.html)
FI (1) FI76092C (cg-RX-API-DMAC7.html)
GR (1) GR78582B (cg-RX-API-DMAC7.html)
HK (1) HK20588A (cg-RX-API-DMAC7.html)
HU (1) HU187068B (cg-RX-API-DMAC7.html)
IE (1) IE54628B1 (cg-RX-API-DMAC7.html)
IL (1) IL68453A (cg-RX-API-DMAC7.html)
NO (1) NO156202C (cg-RX-API-DMAC7.html)
NZ (1) NZ203988A (cg-RX-API-DMAC7.html)
PH (1) PH18035A (cg-RX-API-DMAC7.html)
PL (1) PL134978B1 (cg-RX-API-DMAC7.html)
PT (1) PT76587B (cg-RX-API-DMAC7.html)
SG (1) SG104087G (cg-RX-API-DMAC7.html)
SU (1) SU1138030A3 (cg-RX-API-DMAC7.html)
YU (1) YU43170B (cg-RX-API-DMAC7.html)
ZA (1) ZA832845B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
EP0247156B1 (en) * 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
KR100314558B1 (ko) * 1994-05-02 2002-02-28 시오노 호히코 피롤리딜티오카르바페넴유도체의결정과,상기결정을함유한동결건조제제및그제조방법
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
BR0313831A (pt) 2002-08-29 2005-07-05 Taisho Pharmaceutical Co Ltd Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
BRPI0408716B1 (pt) * 2003-03-27 2017-08-29 Basilea Pharmaceutica Ag. Cefalosporin in crystalline form, process for its preparation and its uses, and preparation of cephalosporin
KR20060108692A (ko) * 2003-10-31 2006-10-18 알자 코포레이션 메트포르민의 개선된 흡수를 위한 조성물 및 제형
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
EP2253615B1 (en) 2007-08-22 2014-07-09 AstraZeneca AB Cyclopropyl amide derivatives
PE20121470A1 (es) 2007-10-26 2012-11-18 Univ California Compuestos de diarilhidantoina como antagonistas del receptor de androgeno
EA018907B1 (ru) * 2009-01-30 2013-11-29 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Кристаллический гидрохлорид n-{(1s)-2-амино-1-[(3-фторфенил)метил]этил}-5-хлор-4-(4-хлор-1-метил-1h-пиразол-5-ил)-2-тиофенкарбоксамида
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
JP2012532886A (ja) * 2009-07-10 2012-12-20 エボルバ アクチェンゲゼルシャフト ジイン組成物
JP5746718B2 (ja) * 2010-02-18 2015-07-08 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag シクロプロピルアミド誘導体からなる固体形態
US20110201623A1 (en) * 2010-02-18 2011-08-18 Uczynski Michael A Crystalline Form Of A Cyclopropyl Benzamide Derivative
CN104903289B (zh) * 2012-12-03 2017-06-09 株式会社钟化 还元型辅酶q10衍生物及其制造方法
WO2015034031A1 (ja) * 2013-09-05 2015-03-12 田辺三菱製薬株式会社 新規な結晶性アリールアルキルアミン化合物およびその製造方法
HRP20201343T1 (hr) * 2014-10-21 2020-11-27 Ariad Pharmaceuticals, Inc. Kristalni oblici 5-kloro-n4-[-2-(dimetilfosforil)fenil]-n2-{2-metoksi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidin-2,4-diamina
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
LT3390358T (lt) * 2016-01-22 2020-11-25 Sandoz Ag Kristalinis eravaciklino bis-hidrochloridas
IL263996B2 (en) 2016-07-07 2024-03-01 Ironwood Pharmaceuticals Inc Solid forms of an sgc stimulator
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD994822S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
JP2024506382A (ja) * 2021-02-15 2024-02-13 プロペラ セラピューティクス インコーポレイテッド アビラテロンプロドラッグ
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
KR20240008356A (ko) * 2021-05-14 2024-01-18 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정제의 고체 형태
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
CN118679157A (zh) * 2021-12-28 2024-09-20 深圳扬厉医药技术有限公司 四氢环庚吲唑化合物的盐型、晶型
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301170S (en) 2023-04-28 2024-06-26 Hs Produkt D O O Firearm
WO2025019497A2 (en) * 2023-07-17 2025-01-23 Kura Oncology, Inc. Crystalline forms of a menin inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DD209632A5 (de) 1984-05-16
AU1387183A (en) 1983-11-17
US4432987A (en) 1984-02-21
PL241553A1 (en) 1983-11-21
FI831392A0 (fi) 1983-04-22
DK101783D0 (da) 1983-02-28
SU1138030A3 (ru) 1985-01-30
FI76092B (fi) 1988-05-31
JPS58201792A (ja) 1983-11-24
DK101783A (da) 1983-10-24
EP0092968A1 (en) 1983-11-02
SG104087G (en) 1988-07-15
IE54628B1 (en) 1989-12-20
KR840004437A (ko) 1984-10-15
ZA832845B (en) 1984-11-28
EP0092968B1 (en) 1986-03-12
CA1187484A (en) 1985-05-21
HU187068B (en) 1985-11-28
IE830926L (en) 1983-10-23
HK20588A (en) 1988-03-25
YU90483A (en) 1986-04-30
EG16412A (en) 1989-03-30
PH18035A (en) 1985-03-06
JPH0119395B2 (cg-RX-API-DMAC7.html) 1989-04-11
ES8406075A1 (es) 1984-07-01
PT76587B (en) 1986-02-27
DK162168C (da) 1992-03-02
NO156202C (no) 1987-08-19
CS235320B2 (en) 1985-05-15
IL68453A0 (en) 1983-07-31
FI76092C (fi) 1988-09-09
FI831392L (fi) 1983-10-24
IL68453A (en) 1986-08-31
GR78582B (cg-RX-API-DMAC7.html) 1984-09-27
DE3362502D1 (en) 1986-04-17
AU536854B2 (en) 1984-05-24
ES521728A0 (es) 1984-07-01
NO156202B (no) 1987-05-04
PL134978B1 (en) 1985-09-30
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
DK162168B (da) 1991-09-23
KR860001279B1 (ko) 1986-09-05
PT76587A (en) 1983-05-01

Similar Documents

Publication Publication Date Title
YU43170B (en) Process for obtaining crystalline benzo-sulphonate salts of sultamicillin
YU44680B (en) Process for obtaining very pure amorphous form of cephuroxim axetile
YU43545B (en) Process for obtaining n-imidazolylderivatives of bicyclical compounds
YU42767B (en) Process for obtaining crystalline salts of benzothiazin-dioxide
DE3374305D1 (en) Process for the preparation of quaternary ammonium salts
IL70544A (en) Crystalline cephem-acid addition salts and process for their preparation
PL238024A1 (en) Process for preparing stable salts of s-adenosilmethionine
DE3467577D1 (en) Process for the preparation of n-glycidyl compounds
PL243949A1 (en) Process for preparing derivatives of phenyl-cyclobutylamine
YU118880A (en) Process for obtaining salts of thiazolylidene-oxo-propionitrile
PL244495A1 (en) Process for preparing salts of n-phosphonomethylglycin
YU42855B (en) Process for making derivatives of carbazine acid
YU224786A (en) Process for obtaining of indolylalkyl-aminopropanole
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
YU44123B (en) Process for making crystalline natrium cephoperazone
KE3785A (en) Crystalline benzenesulfonate salts of sultamicillin
PL241020A1 (en) Process for preparing derivatives of pterocarpane
AU553252B2 (en) Crystalline salts of cefodizim
YU158584A (en) Process for making salts of antimalaric phenanthrenemethanol compounds
HUT37425A (en) Process for preparing crystalline benzothiazine-dioxide salts
SU1075479A1 (ru) Выпарной аппарат для кристаллизации растворов
PT78548A (en) Process for the preparation bis-alkylphosphonium salts of n-phosphonomethylglycine
PL237537A1 (en) Method of manufacture of crystalline microcellulose
BG33350A1 (en) Method for obtaining of ethelene- bis- dithoicarbamide acid- diammonium salt
PL239852A2 (en) Process for preparation of alpha-amino-epsilon-caprolactam